Webinar on PMS Project Made Easy: Summary of activities and Practical Tips for SMEs, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 February 2025, 14:00 (CET) to 24 February 2025, 16:00 (CET)

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 14, Status: Authorised

Executive Steering Group on Shortages and Safety of Medicinal Products

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised

Non-clinical Working Party

Human medicines European public assessment report (EPAR): Armisarte (previously Pemetrexed Actavis), pemetrexed, Date of authorisation: 18/01/2016, Revision: 15, Status: Authorised

Supporting innovation

Consolidated 3-year work plan for the Emergency Task Force (ETF)

Human medicines European public assessment report (EPAR): Pluvicto, lutetium (177Lu) vipivotide tetraxetan, Date of authorisation: 09/12/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Kinpeygo, budesonide, Date of authorisation: 15/07/2022, Revision: 11, Status: Authorised